206 related articles for article (PubMed ID: 36059381)
1. Contrast-enhanced MR Angiography without Gadolinium-based Contrast Material: Clinical Applications Using Ferumoxytol.
Jalili MH; Yu T; Hassani C; Prosper AE; Finn JP; Bedayat A
Radiol Cardiothorac Imaging; 2022 Aug; 4(4):e210323. PubMed ID: 36059381
[TBL] [Abstract][Full Text] [Related]
2. The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts.
Shah A; Neitzel E; Panda A; Fananapazir G
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38561553
[TBL] [Abstract][Full Text] [Related]
3. Ferumoxytol-enhanced magnetic resonance angiography provides comparable vascular conspicuity to CT angiography in dogs with intrahepatic portosystemic shunts.
Wilson S; Culp WTN; Wisner ER; Cissell DD; Finn JP; Zwingenberger AL
Vet Radiol Ultrasound; 2021 Jul; 62(4):463-470. PubMed ID: 33634935
[TBL] [Abstract][Full Text] [Related]
4. Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art.
Adams LC; Jayapal P; Ramasamy SK; Morakote W; Yeom K; Baratto L; Daldrup-Link HE
AJR Am J Roentgenol; 2023 Apr; 220(4):590-603. PubMed ID: 36197052
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular MRI with ferumoxytol.
Finn JP; Nguyen KL; Han F; Zhou Z; Salusky I; Ayad I; Hu P
Clin Radiol; 2016 Aug; 71(8):796-806. PubMed ID: 27221526
[TBL] [Abstract][Full Text] [Related]
6. High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.
Nayak AB; Luhar A; Hanudel M; Gales B; Hall TR; Finn JP; Salusky IB; Zaritsky J
Pediatr Nephrol; 2015 Mar; 30(3):515-21. PubMed ID: 25212105
[TBL] [Abstract][Full Text] [Related]
7. Vascular Imaging With Ferumoxytol as a Contrast Agent.
Hope MD; Hope TA; Zhu C; Faraji F; Haraldsson H; Ordovas KG; Saloner D
AJR Am J Roentgenol; 2015 Sep; 205(3):W366-73. PubMed ID: 26102308
[TBL] [Abstract][Full Text] [Related]
8. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
[TBL] [Abstract][Full Text] [Related]
9. Ferumoxytol MR Angiography versus Duplex US for Vascular Mapping before Arteriovenous Fistula Surgery for Hemodialysis.
Stoumpos S; Tan A; Hall Barrientos P; Stevenson K; Thomson PC; Kasthuri R; Radjenovic A; Kingsmore DB; Roditi G; Mark PB
Radiology; 2020 Oct; 297(1):214-222. PubMed ID: 32692301
[TBL] [Abstract][Full Text] [Related]
10. Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.
Mukundan S; Steigner ML; Hsiao LL; Malek SK; Tullius SG; Chin MS; Siedlecki AM
Am J Kidney Dis; 2016 Jun; 67(6):984-8. PubMed ID: 26786296
[TBL] [Abstract][Full Text] [Related]
11. Ferumoxytol-enhanced MRI in the peripheral vasculature.
Lehrman ED; Plotnik AN; Hope T; Saloner D
Clin Radiol; 2019 Jan; 74(1):37-50. PubMed ID: 29731126
[TBL] [Abstract][Full Text] [Related]
12. Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease.
Stoumpos S; Hennessy M; Vesey AT; Radjenovic A; Kasthuri R; Kingsmore DB; Mark PB; Roditi G
Eur Radiol; 2019 Jul; 29(7):3543-3552. PubMed ID: 30919067
[TBL] [Abstract][Full Text] [Related]
13. Super High Contrast USPIO-Enhanced Cerebrovascular Angiography Using Ultrashort Time-to-Echo MRI.
Timms L; Zhou T; Qiao J; Gharagouzloo C; Mishra V; Lahoud RM; Chen JW; Harisinghani M; Sridhar S
Int J Biomed Imaging; 2024; 2024():9763364. PubMed ID: 38644981
[TBL] [Abstract][Full Text] [Related]
14. Ferumoxytol-enhanced magnetic resonance angiography is a feasible method for the clinical evaluation of lower extremity arterial disease.
Walker JP; Nosova E; Sigovan M; Rapp J; Grenon MS; Owens CD; Gasper WJ; Saloner DA
Ann Vasc Surg; 2015 Jan; 29(1):63-8. PubMed ID: 25269682
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
[TBL] [Abstract][Full Text] [Related]
16. Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography.
Stabi KL; Bendz LM
Ann Pharmacother; 2011 Dec; 45(12):1571-5. PubMed ID: 22045905
[TBL] [Abstract][Full Text] [Related]
17. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.
Daldrup-Link HE; Theruvath AJ; Rashidi A; Iv M; Majzner RG; Spunt SL; Goodman S; Moseley M
Pediatr Radiol; 2022 Feb; 52(2):354-366. PubMed ID: 34046709
[TBL] [Abstract][Full Text] [Related]
18. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
[TBL] [Abstract][Full Text] [Related]
19. Ferumoxytol-Enhanced Cardiac Magnetic Resonance Angiography and 4D Flow: Safety and Utility in Pediatric and Adult Congenital Heart Disease.
Renella P; Li J; Prosper AE; Finn JP; Nguyen KL
Children (Basel); 2022 Nov; 9(12):. PubMed ID: 36553257
[TBL] [Abstract][Full Text] [Related]
20. Emerging applications for ferumoxytol as a contrast agent in MRI.
Bashir MR; Bhatti L; Marin D; Nelson RC
J Magn Reson Imaging; 2015 Apr; 41(4):884-98. PubMed ID: 24974785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
